Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Designing a Large Language Model Architecture for Shared Decision Making and Informed Intentions (DEONCAI3-1)

15 września 2026 zaktualizowane przez: Felix G. Rebitschek, Harding Center for Risk Literacy

DEONCAi 3-1: Can Large Language Models Support Shared Decision-Making and Informed Intentions in the Field: An Online Experiment Comparing Them to a Standard Model and to an Evidence-Based Decision Aid

This study investigates a novel, agentic Large Language Model (LLM) architecture designed to facilitate Shared Decision-Making (SDM) in healthcare. While patients increasingly use standard LLMs for health information, these models often struggle with multi-turn conversations and fail to adapt to varying reading levels, disadvantaging vulnerable groups. By utilizing an agentic state-machine, this project aims to overcome common LLM deficits-such as context loss and uncritical agreement-to ensure clinically accurate, participatory patient conversations. The study evaluates whether this architecture improves informed decision-making compared to standard LLMs, particularly for patients with low health literacy.

Przegląd badań

Szczegółowy opis

Background & Current State of Research Shared Decision-Making is widely recognized as the gold standard of patient-centered care. However, its successful implementation in clinical practice is frequently hindered by systemic time and budget constraints. Consequently, patients are increasingly turning to Large Language Models to independently access health information and navigate their medical options.

The Problem: Limitations of Standard LLMs Recent studies indicate that using standard LLMs can digitally reproduce existing health inequalities and participation gaps. These models struggle to adapt to different reading levels without a significant loss in quality. While highly developed prompting techniques can enhance clinical accuracy, the results remain highly variable depending on the specific model and technique used.

A central deficit becomes apparent in multi-turn interactions, which are essential for a natural SDM workflow. In these prolonged conversations, standard LLMs tend to exhibit "context rot," leading to a sharp decline in accuracy as the dialogue progresses. This issue is further exacerbated by model sycophancy (an uncritical tendency to agree with the user) and completion eagerness (a tendency to prematurely conclude the conversation). Because current LLMs often fail to meet evidence-based reporting standards and lack systematic validation of user comprehension, the burden of fact-checking remains entirely on the user. This dynamic significantly disadvantages vulnerable groups, particularly those with lower health literacy.

Project Objectives and Research Questions

This project proposes a technical and clinical solution to these challenges through the following core research questions:

Technical-Conceptual Framework: How can we develop a transparent and replicable workflow that formalizes the SDM process through an agentic state-machine, thereby eliminating structural deficits of LLMs (e.g., context rot and sycophancy) in prolonged interactions?

Clinical Evaluation (Primary Objective): Does this newly developed agentic LLM architecture achieve higher scores in participatory conversation management and demonstrate a significantly greater objective increase in informed decision-making among users during multi-turn interactions, compared to a standard baseline LLM?

Health Equity (Secondary Objective): To what extent can this agentic LLM architecture guarantee effective participatory conversation management for vulnerable patient groups with low health literacy?

Typ studiów

Interwencyjne

Zapisy (Szacowany)

330

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Opis

Inclusion Criteria:

  • Biological sex: Female.
  • Age: 40 to 70 years old.
  • Country of residence: United States (US) or United Kingdom (UK).
  • Language: Native English speaker (English as first language).
  • Registered and verified user on the academic research platform Prolific.
  • Able to read, understand, and provide informed consent digitally.

Exclusion Criteria:

  • Individuals who do not meet the automated pre-screening criteria on the Prolific platform.
  • Inability to use or access a computer, smartphone, or internet browser required to complete the digital study.

Note: Quotas will be enforced during recruitment to ensure a 50/50 stratified split between participants with and without university entrance qualifications to guarantee variance in educational backgrounds. Once a quota is filled, further participants matching that educational profile will be excluded.

-

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Badania usług zdrowotnych
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Shared Decision Making Chatbot
Participants will engage in a multi-turn, AI-assisted consultation about mammography screening. They will interact with a newly developed agentic Large Language Model architecture that uses an integrated state-machine designed to actively guide the Shared Decision-Making process, adapt to the user's reading level, and prevent context loss.
An interactive AI chatbot built with an agentic state-machine architecture designed to systematically guide users through the Shared Decision-Making process regarding mammography screening, with built-in ethical guardrails to prevent hallucination and sycophancy.
Aktywny komparator: Standard Chatbot
Participants will engage in a conversation about mammography screening using a standard, usual care Large Language Model (Mistral Large). This model represents the current consumer standard for AI health queries and lacks the specialized agentic state-machine and SDM workflow guidance.
An unmodified, standard generative Large Language Model chatbot acting as a baseline control, used by participants to discuss mammography screening.
Aktywny komparator: Information brochure
Participants will receive and read the standard informational patient brochure on mammography screening published by the German Institute for Quality and Efficiency in Health Care (IQWiG). This represents the current standard of care for patient information.
The standard digital informational brochure on mammography screening provided by the german Institute for Quality and Efficiency in Health Care (IQWiG), used as a usual care baseline for patient education.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Patient-Reported Quality of Shared Decision-Making
Ramy czasowe: Day 1
Assessed using the 9-item Shared Decision Making Questionnaire (SDM-Q-9). This validated instrument measures the patient's perceived involvement in the medical decision-making process. The questionnaire consists of 9 items, each rated on a 6-point scale ranging from 0 ("completely disagree") to 5 ("completely agree"). The raw scores are summed and multiplied by 20/9 to yield a total score ranging from 0 to 100. Higher scores indicate a higher perceived quality and greater patient involvement in shared decision-making.
Day 1

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Multidimensional Informed Decision-Making
Ramy czasowe: Day 1
Based on Marteau's conceptualization of informed decision-making. An informed decision is achieved when a participant has sufficient objective knowledge about mammography screening and their behavioral intention (to screen or not to screen) is congruent with their personal attitudes toward the screening. This is calculated as a composite measure integrating an objective knowledge test, an attitude assessment, and a screening intention question. Higher objective knowledge scores and higher attitude-intention congruence indicate a better-informed decision.
Day 1
Subjective Decisional Conflict
Ramy czasowe: Day 1
Assessed using a standardized Decisional Conflict Scale. This measures the participant's perceived uncertainty in choosing a screening option, their clarity of personal values, and their feeling of being supported in decision-making. Scores are transformed to a 0 to 100 scale. Lower scores indicate less decisional conflict and greater decision certainty.
Day 1
Medical Accuracy and Safety of Generated Information
Ramy czasowe: Day 1
A quantitative and qualitative assessment of the medical accuracy of the AI-generated texts. This is operationalized by counting the frequency (number of occurrences) and categorizing the severity of deviations from established medical evidence (i.e., misinformation or "hallucinations"). These deviations are identified via an integrated ethics module and/or expert review. Lower frequencies and lower severity ratings indicate higher medical accuracy.
Day 1

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Felix G Rebitschek, PhD, Harding Center for Risk Literacy

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

15 września 2026

Zakończenie podstawowe (Szacowany)

30 września 2026

Ukończenie studiów (Szacowany)

30 września 2026

Daty rejestracji na studia

Pierwszy przesłany

9 września 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

15 września 2026

Pierwszy wysłany (Rzeczywisty)

18 września 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

18 września 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

15 września 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

De-identified individual participant data (IPD) underlying the results reported in the published article, including survey data (SDM-Q-9, decisional conflict, knowledge scores) and anonymized dialog transcripts, will be shared.

Ramy czasowe udostępniania IPD

Data will become available immediately following publication of the primary results and will be accessible indefinitely.

Kryteria dostępu do udostępniania IPD

Data will be made publicly available as supplement material on the publishers website to any researcher or individual for non-commercial research purposes.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj